Aurobindo Pharma partners with Covaxx for Covid-19 vaccine in India
Covaxx, is currently conducting phase 1 clinical trial for the vaccine candidate
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Dec 20
Covaxx, is currently conducting phase 1 clinical trial for the vaccine candidate
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 Dec 20
Treatment using tezepelumab did not meet the primary endpoint of statistically significant reduction in the daily OCS dose,…
09 Dec 20
In the interim analysis, the vaccine showed efficacy in preventing Covid-19, with no severe cases or hospitalisations after…
08 Dec 20
INO-4800 is an advanced prophylactic DNA vaccine candidate, designed to work against the activity of SARS-CoV-2, the virus…
19 Nov 20
The primary efficacy analysis in 170 confirmed cases of Covid-19 showed that BNT162b2 is 95% effective in preventing…
17 Nov 20
Moderna intends to seek the US FDA’s Emergency Use Authorisation (EUA) based on the interim data analysis of…
12 Nov 20
The efficacy of the Sputnik V vaccine is calculated based on 20 confirmed Covid-19 cases, who received either…
11 Nov 20
Treatment using tezepelumab in the NAVIGATOR Phase 3 clinical trial was well tolerated in patients with severe asthma
10 Nov 20
The vaccine candidate was more than 90% effective in preventing Covid-19 in participants without prior SARS-CoV-2 infection
04 Nov 20
Vupanorsen is an investigational antisense therapy, discovered by Ionis Pharmaceuticals and co-developed by Ionis and its subsidiary Akcea…